Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.
Press releases published on June 30, 2025
Penn Highlands Healthcare Offers July 4th/Summer Safety Tips
GlobeNewswire
·
June 30, 2025
DuBois, Pennsylvania, June 30, 2025 (GLOBE NEWSWIRE) -- July 4th is our nation’s birthday – a time for parades, picnics, pools and the popping sounds of colorful fireworks in the evening. You can keep yourself and your family safe and healthy this holiday …
Blue Heron Recovery Expands Services with Opening of New Detox Unit in San Antonio
EIN Presswire
·
June 30, 2025
Blue Heron Recovery, a trusted leader in outpatient addiction treatment in San Antonio, proudly announces the grand opening of its new 8-bed Detox Unit SAN ANTONIO, TX, UNITED STATES, June 29, 2025 /EINPresswire.com/ -- Blue Heron Recovery, a trusted …
Zyter|TruCare 25.1 Adds Agentic AI, Mobile Flexibility, and Built-In Regulatory Support for Health Plans and Managed Care Organizations
GlobeNewswire
·
June 30, 2025
Rockville, Maryland, June 30, 2025 (GLOBE NEWSWIRE) -- Zyter|TruCare, a provider of the most widely used population health management technology and services for health plans and managed care organizations, today announced the latest release of its TruCare …
Fibromyalgia Treatment Market Growth | Trends, Innovations & Top Companies 2025 | DataM Intelligence
EIN Presswire
·
June 30, 2025
The Global Fibromyalgia Treatment Market is expected to reach at a CAGR of 4.2 % during the forecast period 2025-2033. AUSTIN, TX, UNITED STATES, June 29, 2025 /EINPresswire.com/ -- The Global Fibromyalgia Treatment Market was worth $2.83 billion in …
Acute Respiratory Distress Syndrome Market Size in the 7MM to Reach USD 5,070.9 Million by 2035
EIN Presswire
·
June 30, 2025
The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, June 29, 2025 /EINPresswire.com/ -- The acute respiratory distress syndrome ( …
Endometriosis Treatment Market Growth | Trends, Therapies & Future Forecast 2025 | DataM Intelligence
EIN Presswire
·
June 30, 2025
The Global Endometriosis Treatment Market is expected to reach at a CAGR of 10.62% during the forecast period 2025-2033. AUSTIN, TX, UNITED STATES, June 29, 2025 /EINPresswire.com/ -- The Global Endometriosis Treatment Market was worth $1.59 billion in …
Heparin Market Growth | Competitive Landscape & Future Projections 2025 | DataM Intelligence
EIN Presswire
·
June 30, 2025
The Global Heparin Market is expected to reach at a CAGR of 3.8% during the forecast period 2025-2033. AUSTIN, TX, UNITED STATES, June 28, 2025 /EINPresswire.com/ -- The Global Heparin Market was valued at $8.75 billion in 2024 and is expected to …
Altezza Travel and Scientists Discover Africa’s Highest-Living Frog on Mount Kilimanjaro
GlobeNewswire
·
June 30, 2025
MOSHI, Tanzania, June 30, 2025 (GLOBE NEWSWIRE) -- Researchers have discovered Africa’s highest-living frog species on Mount Kilimanjaro at an altitude of 4000 meters. The discovery, made by Altezza Travel during a climb in June 2024, led to a scientific …
OSE Immunotherapeutics Publishes Letter to Shareholders
GlobeNewswire
·
June 30, 2025
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders. The Company’s CEO and Board of …
OSE Immunotherapeutics publie une Lettre aux Actionnaires
GlobeNewswire
·
June 30, 2025
OSE Immunotherapeutics publie une Lettre aux Actionnaires NANTES, France, 30 juin 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la publication de sa première Lettre aux Actionnaires. Le Directeur général et le …
Erdem Hospital Launches New Pre-Surgery Education Program for Bariatric Patients
GlobeNewswire
·
June 30, 2025
Photo: Erdem Hospital via FL Communications ISTANBUL, June 30, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for bariatric patients. This initiative marks another …
Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer
GlobeNewswire
·
June 30, 2025
LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal Biotech, a pioneering biotechnology company headquartered in London, today announced a $35 million Series A raise, representing one of Europe's largest investments into a life sciences tools company. This …
Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat
GlobeNewswire
·
June 30, 2025
– The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily demonstrated clinically meaningful reductions in systolic …
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
GlobeNewswire
·
June 30, 2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a …
Acentra Health Earns Fourth Consecutive Recognition on the Washington Business Journal’s Annual ‘Largest Private Companies’ List
GlobeNewswire
·
June 30, 2025
MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, has earned …
Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 30, 2025
WAYNE, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company has been …
Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
GlobeNewswire
·
June 30, 2025
Vancouver, Canada, June 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Senti Bio Participates in Nasdaq Amplify Spotlight Series
GlobeNewswire
·
June 30, 2025
Access the segment here SOUTH SAN FRANCISCO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using …
Joint Commission Launches a Transformative Approach to Healthcare Accreditation
GlobeNewswire
·
June 30, 2025
OAKBROOK TERRACE, Illinois, June 30, 2025 (GLOBE NEWSWIRE) -- Joint Commission today launched Accreditation 360: The New Standard, a transformational approach to hospital and healthcare accreditation and certification. Leveraging data analytics with a …
GCANRx Announces Uplisting to New Market Tier
GlobeNewswire
·
June 30, 2025
BALTIMORE, June 30, 2025 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products is pleased to announce …